Surprisingly, IRIS was uncommon in this study (7%) although subjects had very advanced immunodeficiency, were receiving ART early in their OI treatment course, and had good increases in CD4 counts - all conditions that have been associated with IRIS. This evidence concerns the gene CD4 and Immunodeficiency.